Navigation Links
Drug-Eluting Stents Safe After Heart Attack
Date:3/30/2008

Long-term study indicates they lower restenosis risk and don't increase mortality probability

SUNDAY, March 30 (HealthDay News) -- Drug-eluting stents, the small tubing placed in diseased coronary arteries to keep them open, are more effective than bare-metal stents for heart attack patients, new research shows.

In the largest study yet comparing the long-term effect of drug-eluting stents -- the drug in question retards the growth of arterial cells -- with drug-free ones, Boston researchers report the drug-eluting device lowers the risk of blood vessels narrowing again and doesn't heighten the risk of mortality.

In analyzing data from 7,216 Massachusetts patients who had stents implanted after having suffered a heart attack known as a myocardial infarction (MI), the researchers concluded that those patients who had drug-eluting stents had a 5 percent better chance of the diseased artery remaining open.

Additionally, they found, those who had an MI and got drug-eluting stents were 1.5 percent less likely than patients with bare-metal stents to have another heart attack in the two-year period that was studied. Mortality was 2.8 percent less likely in patients with drug-eluting stents, the researchers said.

The findings follow earlier smaller studies this year that showed the drug-eluting stents may be safe for MI patients but questioned their long-term effectiveness.

The new research was to be presented Sunday at a joint meeting of the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology in Chicago.

"This study confirms that the same benefits that drug-eluting stents offer other patients in preventing restenosis [re-narrowing] of the coronary arteries are still there for patients with MI, and there doesn't appear to be any trade-off in increased risk of repeat MI or death," Dr. Laura Mauri, the study's lead researcher, said in a prepared statement.

"I would feel comfortable considering drug-eluting stents on the basis of these results -- with the caveats that treated patients must be able to take antiplatelet therapy and that we definitely want to see even longer-term follow-up," added Mauri, who is chief scientific officer at the Harvard Clinical Research Institute, as well as a Brigham and Womens Hospital cardiologist and an assistant professor of medicine at Harvard Medical School.

More information

The U.S. government has more information on how stenting works.



-- Barry Hoffman



SOURCE: American College of Cardiology and Society for Cardiovascular Angiography and Interventions, news release, March 30, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
2. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
3. TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
4. New Drug Shows Promise in Use With Coronary Stents
5. Experts Offer Clarity on Confusion Surrounding Stents
6. Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases
7. Study Finds Both Coated Stents Perform the Same
8. Stents Slightly Better Than Bypass for Blocked Left Coronary Artery
9. Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
10. Surgery Better Than Stents for Multiple Blockages
11. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug-Eluting Stents Safe After Heart Attack
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser ... Cancer Institute. For Betsy, the clinical trial has been life-saving as she has ... worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
(Date:1/20/2017)... ... ... a fine examination of how God handles sin, including how to let go of ... who, for over ten long years has been waiting to release this powerful insight about ... has been serving the Lord for over twenty years, and he has been preaching and ...
(Date:1/20/2017)... ... ... and enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is ... a devoted woman of faith. , “Becoming a parent changes you. In my case, ... for years, but actually doing it might have been a while in coming if it ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... , January 19, 2017 Incretin Mimetics/GLP-1 ... and Others The global anti-obesity drugs market ... first half of the forecast period and CAGR of 38.7% in ... to grow at a CAGR of 32.8% from 2016 to 2027. ... in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
Breaking Medicine Technology: